help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2009-0452
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Ota, N.
Right arrow Articles by Toyama, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ota, N.
Right arrow Articles by Toyama, Y.
Endocrinology Vol. 150, No. 11 4823-4834
Copyright © 2009 by The Endocrine Society

Accelerated Cartilage Resorption by Chondroclasts during Bone Fracture Healing in Osteoprotegerin-Deficient Mice

Norikazu Ota, Hironari Takaishi, Naoto Kosaki, Jiro Takito, Masaki Yoda, Takahide Tohmonda, Tokuhiro Kimura, Yasunori Okada, Hisataka Yasuda, Hiroshi Kawaguchi, Morio Matsumoto, Kazuhiro Chiba, Hiroyasu Ikegami and Yoshiaki Toyama

Departments of Orthopaedic Surgery (N.O., H.T., N.K., J.T., M.Y., T.T., K.C., H.I., Y.T.), Pathology (T.K., Y.O.), and Spine and Spinal Cord Disease (M.M.), School of Medicine, Keio University, Tokyo 160-8582, Japan; Nagahama Institute for Biochemical Science (H.Y.), Oriental Yeast Co., Ltd., Shiga 526-0804, Japan; and Sensory and Motor system Medicine (H.K.), Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan

Address all correspondence and requests for reprints to: Dr. Hironari Takaishi, Department of Orthopaedic Surgery, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail: hironari{at}sc.itc.keio.ac.jp.

Receptor activator of nuclear factor-{kappa}B ligand (RANKL) and osteoprotegerin (OPG), a decoy receptor of RANKL, maintain bone mass by regulating the differentiation of osteoclasts, which are bone-resorbing cells. Endochondral bone ossification and bone fracture healing involve cartilage resorption, a less well-understood process that is needed for replacement of cartilage by bone. Here we describe the role of OPG produced by chondrocytes in chondroclastogenesis. Fracture healing in OPG–/– mice showed faster union of the fractured bone, faster resorption of the cartilaginous callus, and an increased number of chondroclasts at the chondroosseous junctions compared with that in wild-type littermates. When a cultured pellet of OPG–/– chondrocytes was transplanted beneath the kidney capsule, the pellet recruited many chondroclasts. The pellet showed the ability to induce tartrate-resistant acid phosphatase-positive multinucleated cells from RAW 264.7 cells in vitro. Finally, OPG–/– chondrocytes (but not wild-type chondrocytes) cultured with spleen cells induced many tartrate-resistant acid phosphatase-positive multinucleated cells. The expression of RANKL and OPG in chondrocytes was regulated by several osteotropic factors including 1,25-dihydroxyvitamin D3, PTHrP, IL-1{alpha}, and TNF-{alpha}. Thus, local OPG produced by chondrocytes probably controls cartilage resorption as a negative regulator for chondrocyte-dependent chondroclastogenesis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society